Pages that link to "Q68174162"
Jump to navigation
Jump to search
The following pages link to Interactions of LDL and modified LDL with mesangial cells and matrix (Q68174162):
Displaying 17 items.
- Advanced glycation end products: a Nephrologist's perspective (Q33848695) (← links)
- Immunological evidence for hypochlorite-modified proteins in human kidney (Q35764605) (← links)
- Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. (Q35833746) (← links)
- Osteopontin deficiency reduces kidney damage from hypercholesterolemia in Apolipoprotein E-deficient mice (Q37049760) (← links)
- Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease (Q37182729) (← links)
- Lipids and the kidney (Q40653054) (← links)
- Cellular mechanisms of lipid injury in the glomerulus (Q40821396) (← links)
- β-Migrating very low density lipoproteins induce foam cell formation in mouse mesangial cells (Q41933216) (← links)
- Tubulointerstitial responses in the progression of glomerular diseases: albuminuria modulates alpha v beta 5 integrin (Q42526002) (← links)
- Lipid modulation in insulin-dependent diabetes mellitus: effect on microvascular outcomes (Q43612181) (← links)
- Understanding AMD by analogy: systematic review of lipid-related common pathogenic mechanisms in AMD, AD, AS and GN. (Q47751388) (← links)
- Native and oxidized low density lipoproteins modulate mesangial cell apoptosis (Q71769791) (← links)
- Oxidized low-density lipoprotein stimulates endothelin-1 release and mRNA expression from rat mesangial cells (Q73031507) (← links)
- Impaired ability of glycated insulin to regulate plasma glucose and stimulate glucose transport and metabolism in mouse abdominal muscle (Q73251961) (← links)
- Uptake and metabolism of lipoprotein-X in mesangial cells (Q73830132) (← links)
- Alzheimer disease (Q74222937) (← links)
- Alzheimer disease (Q85013370) (← links)